Rubius Therapeutics
(NASDAQ:RUBY)
$0.703
-0.032[-4.35%]
At close: Aug 19
$0.73
0.0270[3.84%]
After Hours: 5:46PM EDT
Day High/Low0.7 - 0.77
52 Week High/Low0.65 - 10.47
Open / Close0.74 / 0.7
Float / Outstanding33.4M / 90.4M
Vol / Avg.515.3K / 737.1K
Mkt Cap63.5M
P/E-
50d Avg. Price0.83
Div / Yield-
Payout Ratio-
EPS-0.58
Total Float33.4M

Rubius Therapeutics (NASDAQ:RUBY), Quotes and News Summary

Rubius Therapeutics (NASDAQ: RUBY)

Day High/Low0.7 - 0.77
52 Week High/Low0.65 - 10.47
Open / Close0.74 / 0.7
Float / Outstanding33.4M / 90.4M
Vol / Avg.515.3K / 737.1K
Mkt Cap63.5M
P/E-
50d Avg. Price0.83
Div / Yield-
Payout Ratio-
EPS-0.58
Total Float33.4M
Sector: Health Care.Industry: Biotechnology
Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-07
REV
Q2 2022Est.ActualSurprise
EPS-0.530-0.490 0.0400
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Rubius Therapeutics Questions & Answers

Q
How do I buy Rubius Therapeutics (RUBY) stock?
A

You can purchase shares of Rubius Therapeutics (NASDAQ: RUBY) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Rubius Therapeutics's (RUBY) competitors?
Q
What is the target price for Rubius Therapeutics (RUBY) stock?
A

The latest price target for Rubius Therapeutics (NASDAQ: RUBY) was reported by SVB Leerink on Tuesday, August 9, 2022. The analyst firm set a price target for 1.00 expecting RUBY to rise to within 12 months (a possible 42.25% upside). 10 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Rubius Therapeutics (RUBY)?
A

The stock price for Rubius Therapeutics (NASDAQ: RUBY) is $0.703 last updated Today at August 19, 2022, 8:00 PM UTC.

Q
Does Rubius Therapeutics (RUBY) pay a dividend?
A

There are no upcoming dividends for Rubius Therapeutics.

Q
When is Rubius Therapeutics (NASDAQ:RUBY) reporting earnings?
A

Rubius Therapeutics’s Q3 earnings are confirmed for Monday, November 7, 2022.

Q
Is Rubius Therapeutics (RUBY) going to split?
A

There is no upcoming split for Rubius Therapeutics.

Q
What sector and industry does Rubius Therapeutics (RUBY) operate in?
A

Rubius Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.